• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定具有增强致细胞病变和融合作用的 SARS-CoV-2 高频宿主内刺突变异株。

Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.

机构信息

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.

uOttawa Center for Infection, Immunity and Inflammation (CI3), Ottawa, Ontario, Canada.

出版信息

mBio. 2021 Jun 29;12(3):e0078821. doi: 10.1128/mBio.00788-21.

DOI:10.1128/mBio.00788-21
PMID:34182784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8262852/
Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a virus that is continuously evolving. Although its RNA-dependent RNA polymerase exhibits some exonuclease proofreading activity, viral sequence diversity can be produced by replication errors and host factors. A diversity of genetic variants can be observed in the intrahost viral population structure of infected individuals. Most mutations will follow a neutral molecular evolution and will not make significant contributions to variations within and between infected hosts. Herein, we profiled the intrasample genetic diversity of SARS-CoV-2 variants, also known as quasispecies, using high-throughput sequencing data sets from 15,289 infected individuals and infected cell lines. Despite high mutational background, we identified recurrent intragenetic variable positions in the samples analyzed, including several positions at the end of the gene encoding the viral spike (S) protein. Strikingly, we observed a high frequency of C→A missense mutations resulting in the S protein lacking the last 20 amino acids (SΔ20). We found that this truncated S protein undergoes increased processing and increased syncytium formation, presumably due to escaping M protein retention in intracellular compartments. Our findings suggest the emergence of a high-frequency viral sublineage that is not horizontally transmitted but potentially involved in intrahost disease cytopathic effects. The mutation rate and evolution of RNA viruses correlate with viral adaptation. While most mutations do not make significant contributions to viral molecular evolution, some are naturally selected and produce variants through positive selection. Many SARS-CoV-2 variants have been recently described and show phenotypic selection toward more infectious viruses. Our study describes another type of variant that does not contribute to interhost heterogeneity but rather phenotypic selection toward variants that might have increased cytopathic effects. We identified that a C-terminal truncation of the spike protein removes an important endoplasmic reticulum (ER) retention signal, which consequently results in a spike variant that easily travels through the Golgi complex toward the plasma membrane in a preactivated conformation, leading to increased syncytium formation.

摘要

严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2) 是一种不断进化的病毒。尽管其 RNA 依赖性 RNA 聚合酶具有一定的外切核酸酶校对活性,但病毒序列多样性可以由复制错误和宿主因素产生。在感染个体的病毒种群结构中,可以观察到多种遗传变异。大多数突变将遵循中性分子进化,不会对感染宿主内部和之间的变异做出重大贡献。在此,我们使用来自 15289 名感染者和感染细胞系的高通量测序数据集,对 SARS-CoV-2 变体(也称为准种)的样本内遗传多样性进行了分析。尽管存在很高的突变背景,但我们在分析的样本中鉴定出了基因内遗传可变位置,包括编码病毒刺突 (S) 蛋白基因末端的几个位置。引人注目的是,我们观察到高频 C→A 错义突变导致 S 蛋白缺失最后 20 个氨基酸 (SΔ20)。我们发现这种截短的 S 蛋白经历了更多的加工和更多的合胞体形成,推测是由于逃避了 M 蛋白在细胞内隔室中的保留。我们的研究结果表明,一种高频病毒亚系的出现并非是水平传播的,但可能与宿主内疾病细胞病变效应有关。RNA 病毒的突变率和进化与病毒适应性相关。虽然大多数突变对病毒分子进化没有显著贡献,但有些是自然选择的,通过正选择产生变异。最近描述了许多 SARS-CoV-2 变体,它们表现出对更具传染性病毒的表型选择。我们的研究描述了另一种变体,它不会导致宿主间异质性增加,而是导致对可能具有增加细胞病变效应的变体的表型选择。我们发现,刺突蛋白的 C 端截短去除了一个重要的内质网 (ER) 保留信号,这导致刺突变体很容易在高尔基复合体中以预激活的构象穿过内质网,进而导致合胞体形成增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/bce4cb50c916/mbio.00788-21-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/816a16526f97/mbio.00788-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/e5ec0668a092/mbio.00788-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/6d7c91c96a01/mbio.00788-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/0d3ba64b1952/mbio.00788-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/bce4cb50c916/mbio.00788-21-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/816a16526f97/mbio.00788-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/e5ec0668a092/mbio.00788-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/6d7c91c96a01/mbio.00788-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/0d3ba64b1952/mbio.00788-21-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ccca/8262852/bce4cb50c916/mbio.00788-21-f005.jpg

相似文献

1
Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.鉴定具有增强致细胞病变和融合作用的 SARS-CoV-2 高频宿主内刺突变异株。
mBio. 2021 Jun 29;12(3):e0078821. doi: 10.1128/mBio.00788-21.
2
D614G Substitution of SARS-CoV-2 Spike Protein Increases Syncytium Formation and Virus Titer via Enhanced Furin-Mediated Spike Cleavage.SARS-CoV-2 刺突蛋白 D614G 取代增加合胞体形成和病毒滴度通过增强的弗林蛋白酶介导的刺突裂解。
mBio. 2021 Aug 31;12(4):e0058721. doi: 10.1128/mBio.00587-21. Epub 2021 Jul 27.
3
SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.SARS-CoV-2 准种为流行变异株提供了有利的突变库。
Microbiol Spectr. 2021 Sep 3;9(1):e0026121. doi: 10.1128/Spectrum.00261-21. Epub 2021 Aug 4.
4
Evolutionary and Phenotypic Characterization of Two Spike Mutations in European Lineage 20E of SARS-CoV-2.两种 SARS-CoV-2 欧洲谱系 20E 刺突突变的进化和表型特征。
mBio. 2021 Dec 21;12(6):e0231521. doi: 10.1128/mBio.02315-21. Epub 2021 Nov 16.
5
Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain.SARS-CoV-2 刺突蛋白 N 端结构域中和抗体表位的宿主内非同义多样性。
Clin Microbiol Infect. 2021 Sep;27(9):1350.e1-1350.e5. doi: 10.1016/j.cmi.2020.10.030. Epub 2020 Nov 2.
6
Molecular Evolution of Human Coronavirus 229E in Hong Kong and a Fatal COVID-19 Case Involving Coinfection with a Novel Human Coronavirus 229E Genogroup.人冠状病毒 229E 在香港的分子进化及涉及新型人冠状病毒 229E 基因群共感染的致死性 COVID-19 病例。
mSphere. 2021 Feb 10;6(1):e00819-20. doi: 10.1128/mSphere.00819-20.
7
Targeted Hybridization Capture of SARS-CoV-2 and Metagenomics Enables Genetic Variant Discovery and Nasal Microbiome Insights.靶向杂交捕获 SARS-CoV-2 和宏基因组学可实现遗传变异发现和鼻腔微生物组学见解。
Microbiol Spectr. 2021 Oct 31;9(2):e0019721. doi: 10.1128/Spectrum.00197-21. Epub 2021 Sep 1.
8
Evolution, Mode of Transmission, and Mutational Landscape of Newly Emerging SARS-CoV-2 Variants.新型 SARS-CoV-2 变异株的进化、传播模式和突变特征。
mBio. 2021 Aug 31;12(4):e0114021. doi: 10.1128/mBio.01140-21.
9
Sequencing Using a Two-Step Strategy Reveals High Genetic Diversity in the S Gene of SARS-CoV-2 after a High-Transmission Period in Tunis, Tunisia.两步策略测序揭示突尼斯高传播期后 SARS-CoV-2 S 基因的高遗传多样性。
Microbiol Spectr. 2021 Dec 22;9(3):e0063921. doi: 10.1128/Spectrum.00639-21. Epub 2021 Nov 10.
10
Evolutionary Tracking of SARS-CoV-2 Genetic Variants Highlights an Intricate Balance of Stabilizing and Destabilizing Mutations.SARS-CoV-2 基因变异的进化追踪突显了稳定和不稳定突变之间的复杂平衡。
mBio. 2021 Aug 31;12(4):e0118821. doi: 10.1128/mBio.01188-21. Epub 2021 Jul 20.

引用本文的文献

1
Characterization of Nanobody Binding to Distinct Regions of the SARS-CoV-2 Spike Protein by Flow Virometry.通过流式病毒测量法对纳米抗体与严重急性呼吸综合征冠状病毒2刺突蛋白不同区域的结合进行表征。
Viruses. 2025 Apr 15;17(4):571. doi: 10.3390/v17040571.
2
Sequences in the Cytoplasmic Tail Contribute to the Intracellular Trafficking and the Cell Surface Localization of SARS-CoV-2 Spike Protein.细胞质尾段的序列有助于严重急性呼吸综合征冠状病毒2刺突蛋白的细胞内运输和细胞表面定位。
Biomolecules. 2025 Feb 14;15(2):280. doi: 10.3390/biom15020280.
3
Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination.

本文引用的文献

1
Virus-Mediated Cell-Cell Fusion.病毒介导的细胞融合。
Int J Mol Sci. 2020 Dec 17;21(24):9644. doi: 10.3390/ijms21249644.
2
The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles.SARS-CoV-2 的包膜和膜蛋白调节刺突蛋白的成熟和保留,从而允许病毒样颗粒的组装。
J Biol Chem. 2021 Jan-Jun;296:100111. doi: 10.1074/jbc.RA120.016175. Epub 2020 Dec 3.
3
Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology.
停止传播渥太华(SSO)队列研究结果:一项加拿大城市为基础的前瞻性评估 SARS-CoV-2 感染和疫苗接种后的抗体反应和中和效率。
BMJ Open. 2023 Oct 31;13(10):e077714. doi: 10.1136/bmjopen-2023-077714.
4
SARS-CoV-2 Syncytium under the Radar: Molecular Insights of the Spike-Induced Syncytia and Potential Strategies to Limit SARS-CoV-2 Replication.SARS-CoV-2合胞体未被关注:刺突蛋白诱导合胞体的分子见解及限制SARS-CoV-2复制的潜在策略
J Clin Med. 2023 Sep 20;12(18):6079. doi: 10.3390/jcm12186079.
5
Innovative, rapid, high-throughput method for drug repurposing in a pandemic-A case study of SARS-CoV-2 and COVID-19.大流行中药物重新利用的创新、快速、高通量方法——以严重急性呼吸综合征冠状病毒2和2019冠状病毒病为例
Front Pharmacol. 2023 Mar 1;14:1130828. doi: 10.3389/fphar.2023.1130828. eCollection 2023.
6
SARS-CoV-2 Omicron subvariants exhibit distinct fusogenicity, but similar sensitivity, to pan-CoV fusion inhibitors.SARS-CoV-2 奥密克戎亚变体对泛冠状病毒融合抑制剂表现出不同的融合性,但敏感性相似。
Emerg Microbes Infect. 2023 Dec;12(1):2178241. doi: 10.1080/22221751.2023.2178241.
7
A loop-mediated isothermal amplification-enabled analytical assay for the detection of SARS-CoV-2: A review.一种基于环介导等温扩增的 SARS-CoV-2 检测分析方法:综述。
Front Cell Infect Microbiol. 2022 Dec 23;12:1068015. doi: 10.3389/fcimb.2022.1068015. eCollection 2022.
8
Interpretable and Predictive Deep Neural Network Modeling of the SARS-CoV-2 Spike Protein Sequence to Predict COVID-19 Disease Severity.用于预测COVID-19疾病严重程度的SARS-CoV-2刺突蛋白序列的可解释性和预测性深度神经网络建模
Biology (Basel). 2022 Dec 8;11(12):1786. doi: 10.3390/biology11121786.
9
SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding.从持续性鼻咽拭子脱落患者中分析 SARS-CoV-2 准种。
Sci Rep. 2022 Nov 4;12(1):18721. doi: 10.1038/s41598-022-22060-z.
10
Intrahost SARS-CoV-2 k-mer Identification Method (iSKIM) for Rapid Detection of Mutations of Concern Reveals Emergence of Global Mutation Patterns.宿主内 SARS-CoV-2 k -mer 识别方法(iSKIM)用于快速检测关注的突变,揭示了全球突变模式的出现。
Viruses. 2022 Sep 27;14(10):2128. doi: 10.3390/v14102128.
病毒 RNA 的持续存在、肺泡细胞融合和血栓形成是 COVID-19 晚期病理学的特征。
EBioMedicine. 2020 Nov;61:103104. doi: 10.1016/j.ebiom.2020.103104. Epub 2020 Nov 3.
4
Coronavirus biology and replication: implications for SARS-CoV-2.冠状病毒的生物学与复制:对 SARS-CoV-2 的启示。
Nat Rev Microbiol. 2021 Mar;19(3):155-170. doi: 10.1038/s41579-020-00468-6. Epub 2020 Oct 28.
5
Syncytia formation by SARS-CoV-2-infected cells.SARS-CoV-2 感染细胞的合胞体形成。
EMBO J. 2020 Dec 1;39(23):e106267. doi: 10.15252/embj.2020106267. Epub 2020 Nov 4.
6
Characteristics of SARS-CoV-2 and COVID-19.SARS-CoV-2 和 COVID-19 的特征。
Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6.
7
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition.一种复制型水疱性口炎病毒,用于研究 SARS-CoV-2 刺突介导的细胞进入及其抑制作用。
Cell Host Microbe. 2020 Sep 9;28(3):486-496.e6. doi: 10.1016/j.chom.2020.06.020. Epub 2020 Jul 3.
8
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2.复制型 VSV-SARS-CoV-2 和 SARS-CoV-2 临床分离株的中和抗体和可溶性 ACE2 抑制作用。
Cell Host Microbe. 2020 Sep 9;28(3):475-485.e5. doi: 10.1016/j.chom.2020.06.021. Epub 2020 Jul 3.
9
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses.使用假型和嵌合病毒来测量 SARS-CoV-2 中和抗体活性。
J Exp Med. 2020 Nov 2;217(11). doi: 10.1084/jem.20201181.
10
The molecular virology of coronaviruses.冠状病毒的分子病毒学。
J Biol Chem. 2020 Sep 11;295(37):12910-12934. doi: 10.1074/jbc.REV120.013930. Epub 2020 Jul 13.